Skip to main content

Abeona Therapeutics Inc.

ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000318306

In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Abeona Therapeutics Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of ABEO: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders5644−12
Shares32.6M20.9M−11.7M (−35.9%)
Value$10.3M$4.51M−$5.77M (−56.1%)

New holders (2)

Institutions that held Abeona Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to ABEO in Q2 2022
InstitutionSharesValue% of portfolio
B. Riley Wealth Management, Inc.12,900$3.00K0.00%
Truvestments Capital LLC1,380$00.00%

Sold out (14)

Institutions that held Abeona Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of ABEO in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
AIGH Capital Management LLC5,025,100$1.58M
Point72 Asset Management, L.P.3,200,000$1.01M
Franklin Resources Inc325,000$102.0K
Assenagon Asset Management S.A.219,587$69.0K
HRT Financial LP99,062$31.0K
Citadel Advisors LLC93,987$29.0K
Citigroup Inc86,935$27.0K
Migdal Insurance & Financial Holdings Ltd.77,500$24.0K
Stratos Wealth Partners, LTD.40,000$13.0K
Two Sigma Securities, LLC27,103$9.00K
Warberg Asset Management LLC22,313$7.00K
Money Concepts Capital Corp5,000$2.00K
Webster Bank, N. A.85$0
Simplex Trading, LLC1,952$0